Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease.
Ratings
4.5 / 5
19 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Michael A. Mussallem$52.3B
Market Cap • 22/04/20241999
(há 25 anos)
2000
(24 years ago)
NYSE
ListagemS&P500 Participant
Index Composite • 2024
Irvine
Sede • California17.300
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
EWSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.